Docstoc

Penile Cancer - Pipeline Review, Q3 2011-ReportsnReports.com

Document Sample
Penile Cancer - Pipeline Review, Q3 2011-ReportsnReports.com Powered By Docstoc
					Penile Cancer - Pipeline Review, Q3 2011

Penile Cancer - Pipeline Review, Q3 2011

Summary

Global Markets Direct’s, 'Penile Cancer - Pipeline Review, Q3 2011', provides an
overview of the Penile Cancer therapeutic pipeline. This report provides information
on the therapeutic development for Penile Cancer, complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic development for Penile Cancer. 'Penile Cancer -
Pipeline Review, Q3 2011' is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope
- A snapshot of the global therapeutic scenario for Penile Cancer.
- A review of the Penile Cancer products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the Penile Cancer pipeline on the basis of therapeutic class, route of
administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description,
mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Browse All Pharmaceuticals Market Research Reports

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Penile Cancer.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most
promising pipeline.
- Devise corrective measures for pipeline projects by understanding Penile Cancer
pipeline depth and focus of Penile Cancer therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying
prospective partners with the most attractive projects to enhance and expand
business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Penile Cancer Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Penile Cancer 7
Penile Cancer Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Penile Cancer Therapeutics - Products under Investigation by Universities/Institutes
13
Penile Cancer - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Combination Products 15
Assessment by Route of Administration 16
Assessment by Molecule Type 18
Drug Profiles 20
Isotretinoin + Interferon alpha-2a - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Docetaxel - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Human Papillomavirus 16 E7 Peptide Vaccine - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Human Papillomavirus 16 E6 Peptide Vaccine - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Docetaxel + Cisplatin + 5-Fluorouracil - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Irinotecan + Cisplatin - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Docetaxel + Cisplatin + 5-Fluorouracil - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Cisplatin + Ifosfamide + Paclitaxel - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 32
Contact Us 32
Disclaimer 32

About Us:

ReportsnReports is an online library of over 100,000+ market research reports and
in-depth market research studies & analysis of over 5000 micro markets. We
provide 24/7 online and offline support to our customers. Get in touch with us for
your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page:
http://www.facebook.com/pages/ReportsnReports/191441427571689



Contact:

Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsandreports.com
http://www.reportsandreports.com
Visit our Market Research Blog

				
DOCUMENT INFO
Description: This report provides information on the therapeutic development for Penile Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Penile Cancer.